'German pharmaceutical giant Bayer is running into mounting shareholder opposition ahead of its annual meeting on Friday. The company’s investors are faulting management for failing to foresee the risks of its biggest deal ever.
A growing number of shareholders have said they won’t support executives and supervisory board members in the upcoming no-confidence vote. The vote has no legal weight but a low enough approval rating could be risky for the future of CEO Werner Baumann and other managers who were in charge of the $63 billion acquisition of US agriculture giant Monsanto.
“In all good conscience, we can’t exculpate management if so much shareholder value is destroyed,” Ingo Speich, chief of sustainability and corporate governance at Deka Investment, was cited as saying by Bloomberg.
Deka Investment is one of Bayer’s top-10 shareholders, and it will vote against discharging both Bayer’s management and supervisory boards for their actions, Speich said.
According to him, an approval rating below 80 percent would be “damaging to the reputation” of Bayer’s management. “If you have 20 percent of shareholders against you, that’s a lot.”
Bayer’s stock has lost almost 40 percent of its value since the Monsanto acquisition in 2018. The company is currently facing more than 11,000 US lawsuits over Monsanto’s Roundup weed killer and its active ingredient glyphosate.
Baumann has defended the multibillion-dollar takeover, claiming “The Monsanto acquisition was and is a good idea,” and was carried out after careful due diligence.'
Read more: Bayer bosses facing shareholder reckoning over Monsanto deal as cancer lawsuits mount
Did you like this article?
Thank you for your vote!
18 May 2019
Major U.S. brands demand EPA take action to stop pre-harvest spraying of toxic glyphosate on food crops
15 May 2019
Monsanto blowback: Bayer stock crashes to seven year low after $2 billion Roundup cancer verdict
From our advertisers
David Icke Interviewed At The New York Premiere Of Renegade - The David Icke Dot-Connector Videocast
From our advertisers